Anti-Bid antibody [Y8],Abcam,AB32060
Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Application
Flow Cyt (Intra), IP, ICC/IF, IHC-P, WB
Platform ID
BAB725685970
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Specifications
Scientific Background
Target data Induces caspases and apoptosis (PubMed : 14583606). Counters the protective effect of BCL2 (By similarity).. BH3-interacting domain death agonist p15. Induces caspase activation and apoptosis (PubMed : 15661737, PubMed : 32029622). Allows the release of cytochrome c (PubMed : 32029622).. Isoform 1. Induces ICE-like proteases and apoptosis.. Isoform 2. Induces ICE-like proteases and apoptosis.. Isoform 3. Does not induce apoptosis.. Isoform 4. Induces ICE-like proteases and apoptosis. See full target information BID
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Please provide the required information below so that we can quickly source your products.